Beta Technology Ltd Company Profile

02:17 EDT 22nd March 2018 | BioPortfolio

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE.

Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later went on to set up an employment agency hiring out scientists to industry such as British Steel (Corus), the National Physical Laboratory (NPL) and the Central Science Laboratory (CSL).

Since then the company has grown in size and taken on more public sector contracts from organisations such as the DTI, DEFRA (formally known as MAFF), Yorkshire Forward, European Commission (EC), Advantage West Midlands and One NorthEast.

Today Beta's main objective is to encourage small and large companies throughout the UK to be more technically proactive.

Beta does this by providing assistance to companies wanting to apply for European research and development funding and by providing innovation services to companies to help them develop, promote and acquire new technologies.

Beta is the designated UK National Contact Point (NCP) for a number of areas of FP6 including SMEs, Life Sciences and Research and Innovation. Additionally, Beta is the Innovation Relay Centre (IRC) for the Yorkshire and Humber region and is a partner in 5 FP6 projects.

Beta's head office is located in Doncaster, South Yorkshire and we have a subsidiary office in Middlesbrough on Teesside. The Company currently employs 28 full time staff and 40 consultants and researchers.


Barclay CourtDoncaster Carr
South Yorkshire
United Kingdom


Phone: 44 (0) 1302 322633
Fax: 44 (0) 1302 388800

News Articles [295 Associated News Articles listed on BioPortfolio]

Human medicines European public assessment report (EPAR): Dinutuximab beta EUSA (previously Dinutuximab beta Apeiron), dinutuximab beta, Revision: 2, Authorised

AdFrontiers Announcing Beta Launch of Self-Serve Advertising Platform

NEW YORK, Feb. 7, 2018/PRNewswire/ --  AdFrontiersby J Carter Marketing, a leading provider of digital advertising technology, announced today the beta launch Read more...

La Jolla begins clinical trial of LJPC-401 for beta-thalassemia

La Jolla Pharmaceutical Company has started a pivotal clinical study of synthetic human hepcidin (LJPC-401) to treat patients with transfusion-dependent...Read More... The post La Jolla begins clinica...

Gene variant protecting against Alzheimer’s disease decreases plasma beta-amyloid levels

New research from the University of Eastern Finland shows that the APP gene variant protecting against Alzheimer’s disease significantly decreases plasma beta-amyloid levels in a population cohort. ...

Funding round pulls in $2.4M for Beta Bionics

A round of equity and securities financing involving 11 anonymous investors brought in $2.4 million for Beta Bionics, accordi -More- 

Amyloid protein transmission through neurosurgery

(University College London) Amyloid beta pathology -- protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.For the paper,...

ODEM Steps Up Beta Development After €2.2M Raise Beats ICO Pre-Sale Target

ODEM, a Swiss technology company that's employing blockchain, or distributed ledger technology to make international education more accessible and affordable, is also expanding its development Rea...

Danish researchers discover how to convert progenitor cells into beta cells

Human stem cells can now effectively be specialized to create funct

PubMed Articles [1111 Associated PubMed Articles listed on BioPortfolio]

Metformin, beta-cell development, and novel processes following beta-cell ablation in zebrafish.

Type 1 and 2 diabetes are characterized by a loss of insulin-producing beta-cells. Current treatments help maintain blood glucose levels but cannot provide a cure. As such, a vital target for the cure...

Cyclin D2 is sufficient to drive beta cell self-renewal and regeneration.

Diabetes results from an inadequate mass of functional beta cells, due to either beta cell loss caused by autoimmune destruction (Type I diabetes) or beta cell failure in response to insulin resistan...

Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta-cell mass.

Two unmet therapeutic strategies for diabetes treatment are prevention of beta-cell death and stimulation of beta-cell replication. Our aim was to characterise the role of Neuropeptide Y receptors in ...

The lifespan trajectory of neural oscillatory activity in the motor system.

Numerous studies connect beta oscillations in the motor cortices to volitional movement, and beta is known to be aberrant in multiple movement disorders. However, the dynamic interplay between these b...

Brain Beta-Catenin Signalling During Stress and Depression.

Beta-catenin is a protein with dual functions in the cell, playing a role in both adhesion between cells as well as gene transcription via the canonical Wnt signalling pathway. In the canonical Wnt si...

Clinical Trials [2285 Associated Clinical Trials listed on BioPortfolio]

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

We intend to examine the effect of a commercially available nutritional supplement, Beta-hydroxy-beta-methylbutyrate(HMB) on whole-body responses to a sugar load.

Thalassemia Treatment Based on the Stem Cell Technology

In order to study the transplantation effect of hematopoetic stem cells from beta-thalassemia induced pluripotent stem cells. We applied clinical grade source of autologous hematopoietic s...

Interaction Study SLV337/Simvastatin

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

Phase I BP Interferon (IFN) Beta-004

Phase I study aiming at: - establishing the pharmacokinetic profile of interferon beta-1a after i.v. administration of the formulation BioPartners IFN beta-1a without albumin (HSA...

Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

This study is to find out if Interferon-beta (IFN-beta) can recover its effectiveness after a washout period in patients with Multiple Sclerosis who have previously developed neutralizing ...

Companies [521 Associated Companies listed on BioPortfolio]

Beta Technology Ltd

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE. Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later...

Beta Amyloid Org

Beta keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is t...

BETA Healthcare Group

BETA Healthcare Group provides healthcare professional liability coverage to more than 150 hospitals and healthcare facilities in California. As the leading choice of liability in...


Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the hi...


Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and se...

More Information about "Beta Technology Ltd" on BioPortfolio

We have published hundreds of Beta Technology Ltd news stories on BioPortfolio along with dozens of Beta Technology Ltd Clinical Trials and PubMed Articles about Beta Technology Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Beta Technology Ltd Companies in our database. You can also find out about relevant Beta Technology Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record